ARTV · Artiva Biotherapeutics, Inc. · Documents
Market Cap
$499.66M
Shares
48.89M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-11 | 2026-09-08 | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| DEF 14A | 2026-08-03 | 2026-09-08 | |
| 8-K | 2026-07-22 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-05-19 | 2026-05-18 | |
| 8-K | 2026-05-08 | — | |
| 8-K | 2026-05-08 | — | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| Investor Event Transcript | 2026-04-15 | 2026-06-30 | |
| 8-K | 2026-03-10 | — | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-02-24 | 2026-02-18 | |
| 8-K | 2026-02-19 | 2026-02-18 | |
| 8-K | 2025-12-12 | 2025-12-10 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-25 | 2025-06-24 | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-24 | |
| 10-K | 2025-03-24 | 2024-12-31 | |
| 8-K | 2025-03-24 | — | |
| 8-K | 2025-01-29 | 2025-01-28 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-10-22 | 2024-10-21 | |
| 8-K | 2024-08-29 | — | |
| 10-Q | 2024-08-29 | 2024-06-30 | |
| 8-K | 2024-07-22 | — |
Showing 1–36 of 36 filings
Key facts
CIK
1817241
CUSIP
04317A107
13F (30d)
52 filings
52 filers
Visit website
Investor relations